117 related articles for article (PubMed ID: 16734559)
1. Stat1 deficiency exacerbates carditis but not arthritis during experimental lyme borreliosis.
Brown CR; Blaho VA; Fritsche KL; Loiacono CM
J Interferon Cytokine Res; 2006 Jun; 26(6):390-9. PubMed ID: 16734559
[TBL] [Abstract][Full Text] [Related]
2. Infection of Interleukin 17 Receptor A-Deficient C3H Mice with Borrelia burgdorferi Does Not Affect Their Development of Lyme Arthritis and Carditis.
Lasky CE; Jamison KE; Sidelinger DR; Pratt CL; Zhang G; Brown CR
Infect Immun; 2015 Jul; 83(7):2882-8. PubMed ID: 25939508
[TBL] [Abstract][Full Text] [Related]
3. Recruitment of macrophages and polymorphonuclear leukocytes in Lyme carditis.
Montgomery RR; Booth CJ; Wang X; Blaho VA; Malawista SE; Brown CR
Infect Immun; 2007 Feb; 75(2):613-20. PubMed ID: 17101663
[TBL] [Abstract][Full Text] [Related]
4. Adenoviral delivery of interleukin-10 fails to attenuate experimental Lyme disease.
Brown CR; Lai AY; Callen ST; Blaho VA; Hughes JM; Mitchell WJ
Infect Immun; 2008 Dec; 76(12):5500-7. PubMed ID: 18824530
[TBL] [Abstract][Full Text] [Related]
5. Experimental lyme arthritis in the absence of interleukin-4 or gamma interferon.
Brown CR; Reiner SL
Infect Immun; 1999 Jul; 67(7):3329-33. PubMed ID: 10377109
[TBL] [Abstract][Full Text] [Related]
6. Activation of natural killer cells in arthritis-susceptible but not arthritis-resistant mouse strains following Borrelia burgdorferi infection.
Brown CR; Reiner SL
Infect Immun; 1998 Nov; 66(11):5208-14. PubMed ID: 9784524
[TBL] [Abstract][Full Text] [Related]
7. Identification of quantitative trait loci governing arthritis severity and humoral responses in the murine model of Lyme disease.
Weis JJ; McCracken BA; Ma Y; Fairbairn D; Roper RJ; Morrison TB; Weis JH; Zachary JF; Doerge RW; Teuscher C
J Immunol; 1999 Jan; 162(2):948-56. PubMed ID: 9916719
[TBL] [Abstract][Full Text] [Related]
8. CD4+ T helper 1 cells facilitate regression of murine Lyme carditis.
Bockenstedt LK; Kang I; Chang C; Persing D; Hayday A; Barthold SW
Infect Immun; 2001 Sep; 69(9):5264-9. PubMed ID: 11500394
[TBL] [Abstract][Full Text] [Related]
9. T helper phenotype and genetic susceptibility in experimental Lyme disease.
Matyniak JE; Reiner SL
J Exp Med; 1995 Mar; 181(3):1251-4. PubMed ID: 7869043
[TBL] [Abstract][Full Text] [Related]
10. The chemokine receptor CXCR2 ligand KC (CXCL1) mediates neutrophil recruitment and is critical for development of experimental Lyme arthritis and carditis.
Ritzman AM; Hughes-Hanks JM; Blaho VA; Wax LE; Mitchell WJ; Brown CR
Infect Immun; 2010 Nov; 78(11):4593-600. PubMed ID: 20823213
[TBL] [Abstract][Full Text] [Related]
11. Bone-marrow chimeras reveal hemopoietic and nonhemopoietic control of resistance to experimental Lyme arthritis.
Brown CR; Reiner SL
J Immunol; 2000 Aug; 165(3):1446-52. PubMed ID: 10903749
[TBL] [Abstract][Full Text] [Related]
12. Protective antibodies develop, and murine Lyme arthritis regresses, in the absence of MHC class II and CD4+ T cells.
Fikrig E; Barthold SW; Chen M; Chang CH; Flavell RA
J Immunol; 1997 Dec; 159(11):5682-6. PubMed ID: 9548512
[TBL] [Abstract][Full Text] [Related]
13. Borrelia burgdorferi arthritis-associated locus Bbaa1 regulates Lyme arthritis and K/B×N serum transfer arthritis through intrinsic control of type I IFN production.
Ma Y; Bramwell KK; Lochhead RB; Paquette JK; Zachary JF; Weis JH; Teuscher C; Weis JJ
J Immunol; 2014 Dec; 193(12):6050-60. PubMed ID: 25378596
[TBL] [Abstract][Full Text] [Related]
14. Gamma interferon is not required for arthritis resistance in the murine Lyme disease model.
Glickstein L; Edelstein M; Dong JZ
Infect Immun; 2001 Jun; 69(6):3737-43. PubMed ID: 11349038
[TBL] [Abstract][Full Text] [Related]
15. Genes outside the major histocompatibility complex control resistance and susceptibility to experimental Lyme arthritis.
Brown CR; Reiner SL
Med Microbiol Immunol; 2000 Nov; 189(2):85-90. PubMed ID: 11138641
[TBL] [Abstract][Full Text] [Related]
16. Antibody-mediated disease remission in the mouse model of lyme borreliosis.
Barthold SW; Hodzic E; Tunev S; Feng S
Infect Immun; 2006 Aug; 74(8):4817-25. PubMed ID: 16861670
[TBL] [Abstract][Full Text] [Related]
17. Clearance of Borrelia burgdorferi may not be required for resistance to experimental lyme arthritis.
Brown CR; Reiner SL
Infect Immun; 1998 May; 66(5):2065-71. PubMed ID: 9573090
[TBL] [Abstract][Full Text] [Related]
18. The severe combined immunodeficiency (scid) mouse. A laboratory model for the analysis of Lyme arthritis and carditis.
Schaible UE; Kramer MD; Museteanu C; Zimmer G; Mossmann H; Simon MM
J Exp Med; 1989 Oct; 170(4):1427-32. PubMed ID: 2794862
[TBL] [Abstract][Full Text] [Related]
19. Cutting edge: T cell-mediated pathology in murine Lyme borreliosis.
McKisic MD; Redmond WL; Barthold SW
J Immunol; 2000 Jun; 164(12):6096-9. PubMed ID: 10843657
[TBL] [Abstract][Full Text] [Related]
20. Interferon-γ influences the composition of leukocytic infiltrates in murine lyme carditis.
Sabino GJ; Hwang SJ; McAllister SC; Mena P; Furie MB
Am J Pathol; 2011 Oct; 179(4):1917-28. PubMed ID: 21820995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
